Functional pancreatic beta cells produced from stem cells
10 March, 2022Researchers have found a way to optimise the functionality of pancreatic cells produced from stem cells, paving the way for cell therapies for diabetes.
ADHD linked to hoarding behaviour
04 March, 2022Almost one in five people with ADHD exhibited clinically significant levels of hoarding, indicating that there could be a hidden population of adults struggling with hoarding.
Mouse model suggests why women are more prone to Alzheimer's
03 March, 2022Female mice with mutations associated with Alzheimer's disease had a faster decline in long-term potentiation (LTP) compared to mutant male mice.
TGA approves AstraZeneca's COVID-19 preventative treatment
02 March, 2022The combination therapy is intended for the prevention of COVID-19 in people who are at risk of infection but have not been exposed to the virus.
Immunotherapy approach induces peanut allergy remission
01 March, 2022After 18 months of treatment, 51% of children who received the oral immunotherapy achieved clinical remission and were able to stop treatment altogether.
'Jekyll and Hyde' bacteria behind respiratory infections
25 February, 2022Researchers were able to deactivate a protein critical to the survival of Haemophilus influenzae bacteria, which colonises the respiratory tract from early childhood.
How the brain drives mice to seek social contact
18 February, 2022Researchers found that social contact-seeking behaviour in mice is driven by the peptide amylin in the medial preoptic area (MPOA) of the forebrain.
Moderate exercise post-vaccine may provide an immunity boost
17 February, 2022Researchers have found that 90 minutes of mild- to moderate-intensity exercise directly after a flu or COVID-19 vaccine may provide an extra immunity boost.
Up-to-date COVID vaccination now includes booster
11 February, 2022 by Lauren DavisAustralians 16 and over should receive a booster dose three months after their primary course, with AstraZeneca approved as a booster by the TGA and Novavax soon set to apply for approval.
Neonatal rotavirus vaccine trialled in Africa
08 February, 2022A reduced dose of an Australian-developed rotavirus vaccine produced a robust immune response in children at risk from deadly diarrhoeal disease in Africa.
Peanut immunotherapy trialled in preschool-aged children
03 February, 2022The majority of participants achieved desensitisation after two and a half years of treatment, and one in five remained in remission 26 weeks after treatment ended.
Zika vaccine shows promising results in animal studies
01 February, 2022A Zika virus vaccine candidate has been shown to be effective at preventing the virus from passing from mother to foetus in preclinical animal studies.
Breaking bacterial resistance to frontline antibiotics
14 January, 2022Researchers have discovered how to repurpose a molecule called PBT2 to break bacterial resistance to commonly used frontline antibiotics.
How pain and anxiety impact breathing on a cellular level
13 January, 2022Scientists at the Salk Institute have uncovered a neural network in the brain that coordinates breathing rhythm with feelings of pain and fear.
Coffee consumption could lower Alzheimer's risk
23 December, 2021Study participants with no memory impairments and with higher coffee consumption had lower risk of transitioning to mild cognitive impairment or developing Alzheimer's disease.
